GSK plc (GSK.L)

1,728.50 +23.50 (+1.38%) 收市：05:19PM BST

GSK plc

980 Great West Road
Middlesex
Brentford TW8 9GS
United Kingdom
44 20 8047 5000
https://www.gsk.com

版塊: Healthcare
行業: Drug Manufacturers - General
全職員工: 70,212

高階主管

名稱	頭銜	支付	行使價	出生年份
Ms. Emma Natasha Walmsley	CEO & Director	5.39M	53.92M	1969
Ms. Julie Belita Brown	CFO & Executive Director	5.14M	無	1962
Ms. Shobie Ramakrishnan	Chief Digital & Technology Officer	無	無	1971
Mr. Tony Wood	Chief Scientific Officer and Head of R&D	無	無	無
Ms. Sarah Elton-Farr	Head of Investor Relations	無	無	無
Mr. James Ford	Senior VP & Group General Counsel of Legal & Compliance	無	無	無
Ms. Sally Jackson	Senior Vice President of Global Communications & CEO Office	無	無	無
Mr. David Simon Redfern BSc (Hons), CA	President of Corporate Development	無	無	1966
Ms. Diana Conrad	Chief People Officer	無	無	無
Mr. Philip C. Thomson	President of Global Affairs	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 GBp。

描述

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

公司管治

截至 2024年5月1日 止，GSK plc 的 ISS 管治質素評分為 9。 Pillar 分數正在審核中：10；董事會：5；股東權利：1；現金賠償：9。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。